Nivalis Therapeutics (NVLS)

Add to Watchlists
Create an Alert
2.34 +0.03  +1.30% NASDAQ Jun 23, 20:00 Delayed 2m USD

Nivalis Therapeutics Total Assets (Quarterly):

53.01M for March 31, 2017
View 4,000+ financial data types
View Full Chart

Nivalis Therapeutics Total Assets (Quarterly) Chart

Export Data
Save Image
Print Image

Nivalis Therapeutics Historical Total Assets (Quarterly) Data

View and export this data going back to 2014. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2017 53.01M
Dec. 31, 2016 61.94M
Sept. 30, 2016 67.34M
June 30, 2016 74.56M
March 31, 2016 80.94M
Dec. 31, 2015 87.91M
Sept. 30, 2015 93.84M
June 30, 2015 101.25M
March 31, 2015 26.30M
Dec. 31, 2014 28.54M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Total Assets

The sum of all current and long-term assets held by a company. An asset is any item with economic value that is held by a company.
Learn More


NVLS Total Assets (Quarterly) Benchmarks

Argos Therapeutics 29.84M
AMAG Pharmaceuticals 2.422B
Progenics Pharmaceuticals 182.85M

NVLS Total Assets (Quarterly) Range, Past 5 Years

Minimum 26.30M Mar 2015
Maximum 101.25M Jun 2015
Average 67.56M

NVLS Total Assets (Quarterly) Excel Add-In Codes

  • Metric Code: assets
  • Latest data point: =YCP("NVLS", "assets")
  • Last 5 data points: =YCS("NVLS", "assets", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.




Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.